Psychostimulant use tied to placental complications

November 15, 2017

(HealthDay)—Psychostimulant use during pregnancy is associated with a small increased relative risk of preeclampsia and preterm birth, according to a study published online Nov. 7 in Obstetrics & Gynecology.

Jacqueline M. Cohen, Ph.D., from Brigham and Women's Hospital in Boston, and colleagues examined data from a cohort of pregnant women and their liveborn neonates enrolled in Medicaid (from 2000 to 2010) to assess whether psychostimulants used to treat attention-deficit/hyperactivity disorder (ADHD) are associated with risk of adverse placental-associated outcomes. They compared women who received amphetamine-dextroamphetamine (n = 3,331) or methylphenidate monotherapy (n = 1,515) in the first half of pregnancy to those who received atomoxetine, a nonstimulant ADHD medication, as a negative control exposure (n = 453) and 1,461,493 unexposed pregnancies.

The researchers found that the adjusted risk ratio for stimulant use was 1.29 for preeclampsia (95 percent confidence interval [CI], 1.11 to 1.49), 1.13 for (95 percent CI, 0.88 to 1.44), 0.91 for small for gestational age (95 percent CI, 0.77 to 1.07), and 1.06 for (95 percent CI, 0.97 to 1.16). The adjusted risk ratio for continuation of stimulant use in the latter half of pregnancy (n = 1,319) was 1.26 for preeclampsia (95 percent CI, 0.94 to 1.67), 1.08 for placental abruption (95 percent CI, 0.67 to 1.74), 1.37 for small for (95 percent CI, 0.97 to 1.93), and 1.3 for preterm birth (95 percent CI, 1.1 to 1.55) compared with discontinuation (n = 3,527).

"The absolute increases in risks are small and, thus, women with significant ADHD should not be counseled to suspend their ADHD treatment based on these findings," conclude the authors.

Several authors disclosed financial ties to the pharmaceutical industry.

Explore further: Prenatal exposure to ADHD meds tied to neonatal morbidity

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Prenatal exposure to ADHD meds tied to neonatal morbidity

November 13, 2017
(HealthDay)—Exposure to attention-deficit/hyperactivity disorder (ADHD) medication during pregnancy is associated with increased risk of neonatal morbidity, according to a study published online Nov. 10 in Pediatrics.

Eclampsia tied to increased relative risk of seizure disorder

November 10, 2017
(HealthDay)—The relative risk of a seizure disorder after eclampsia is higher than that of women unaffected by eclampsia but remains extremely low, according to a study published online Nov. 7 in Obstetrics & Gynecology.

Risk of certain adverse outcomes up with endoscopy in pregnancy

February 7, 2017
(HealthDay)—Endoscopy during pregnancy is associated with increased risk of preterm birth or small for gestational age, according to a study published in the February issue of Gastroenterology.

In vitro fertilization linked with increased risk of spontaneous preterm birth

November 8, 2017
A new analysis of published studies found an approximate 80% increased risk of spontaneous preterm birth (both before 37 and 34 weeks) when women become pregnant via in vitro fertilization (IVF) than through spontaneous conception.

Sleep-disordered breathing may affect pregnancy outcomes

July 8, 2014
(HealthDay)—Sleep-disordered breathing (SDB) may be associated with adverse pregnancy outcomes, according to research published in the June issue of the American Journal of Obstetrics & Gynecology.

Overall favorable outcomes for twin pregnancies in moms 45-plus

April 11, 2017
(HealthDay)—Twin pregnancies in older women (at least 45 years of age) overall have favorable outcomes but are associated with high rates of some complications, according to a study published in the May issue of Obstetrics ...

Recommended for you

Womb natural killer cell discovery could lead to screening for miscarriage risk

December 14, 2017
For the first time the functions of natural killer cells in the womb have been identified.

Hormone discovery marks breakthough in understanding fertility

December 12, 2017
Scientists at The University of Nottingham have shown, for the first time, that a naturally occurring hormone plays a vital part in regulating a woman's fertility, a discovery that could lead to better diagnosis and treatment ...

Study reveals Viagra to be 'ineffective' for fetal growth restriction

December 8, 2017
A University of Liverpool led international clinical trial has found an anti-impotence drug to be ineffective at improving outcomes for pregnancies complicated by fetal growth restriction.

Obese first-time mums more likely to have premature babies

December 4, 2017
Obese women are up to three times more likely to have a premature child during their first pregnancy, according to a study from University College Dublin.

Stillbirth is not just stillbirth—more information is needed

December 4, 2017
Forty two babies are stillborn in Australia every week, and 60 per cent of them are recorded as "unexplained".

First baby from a uterus transplant in the US born in Dallas

December 2, 2017
The first birth as a result of a womb transplant in the United States has occurred in Texas, a milestone for the U.S. but one achieved several years ago in Sweden.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.